Effect of intra-abdominal, preperitoneal application of a local anesthetic during minimally invasive inguinal hernia repair (TAPP) on development of chronic pain syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035812

Enrollment

200

Registered

2025-01-02

Start date

2024-03-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unilateral inguinal hernia

Interventions

Group 1: Install 100mg ropivacaine intra-abdominal, preperitoneal Group 2: Install 100mg placebo (Nacl) intra-abdominal, preperitoneal

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: unilateral inguinal hernia

Exclusion criteria

Exclusion criteria: bilateral inguinal hernia, existing pain syndrome, drainage system necessary, emergency surgery / incarceration, lack of consent form, age <18 years

Design outcomes

Primary

Measure	Time frame
Degree of pain (NRS) one year after surgery	—

Secondary

Measure	Time frame
Postoperative pain, use of pain medication within the first 24 hours	—

Countries

Germany

Contacts

Public ContactMathias Sontag

Josephs Hospital Warendorf

M.sontag@jhwaf.de+492581201301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026